Study finds breast cancer risk not connected to insulin

09/4/2013 | PhysiciansBriefing.com

The use of various insulin types was not linked to breast cancer risk in women with diabetes regardless of dosage, duration of use and tumor stage, a study in Diabetes Care indicated. Data showed the odds ratio of breast cancer after 3.2 years of insulin use was 1.04 for patients who used glargine, 1.23 for those who took lispro, 0.95 for those who used aspart and 0.81 for those on human insulin.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID